Israel stocks rise, led by Teva, ICL - MarketWatch
Israel stocks rise as investors key on Teva, ICL - MarketWatch
Mylan tries to fend off Teva with bigger bid for Perrigo - MarketWatch
Teva Pharmaceutical Shares Real-World Data Of ProAir Digihaler In Asthma Patients
What To Do After TEVA Stock Falls Below $10 Again (NYSE:TEVA) | Seeking Alpha
Teva Stock Climbs as Earnings Hint at Turnaround | Barron's
Teva releases generic version of Mylan's EpiPen in limited doses in the U.S. - MarketWatch
Deckers racked up $2 billion in Ugg boots sales in record year; stock jumps 14% - MarketWatch
Israel stocks fall for fifth day; Teva rises - MarketWatch
TEVA — TradingView
What To Do After TEVA Stock Falls Below $10 Again (NYSE:TEVA) | Seeking Alpha
Teva earnings preview: Opioid suits are 'key' - MarketWatch
Teva Pharmaceutical Industries Ltd. (TEVA) Moves 7.5% Higher: Will This Strength Last?
Teva Pharmaceuticals reports earnings on Wednesday. Here's what to expect - MarketWatch
Three health-care deals today are paying huge premiums - MarketWatch
Israel stocks up; FTC eyes Teva-Cephalon deal - MarketWatch
Leaner, More Agile Teva Sees Brighter Days Ahead
Market News
Teva beats first-quarter expectations but still has the same old problems - MarketWatch
Drugmaker Teva Pharmaceuticals found guilty for contribution to opioid crisis - MarketWatch
Teva's Earnings and Outlook Miss Estimates. Currency Moves Are to Blame. | Barron's
Perrigo rejects Mylan, opening door for Teva - MarketWatch
